Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diastika Biotekindo Tbk. (CHEK) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Diastika Biotekindo Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Diastika Biotekindo Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Diastika Biotekindo Tbk. trades at Rp126 (market cap 514.17B, 1.22M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Diastika Biotekindo Tbk. is the larger of the two by market cap, and Diastika Biotekindo Tbk. is more actively traded (1.22M versus 963.6K). Which is the better fit depends on your goals.

CHEKDGNS
Market Cap
514.17B310.75B
Volume
1.22M963.6K
Lot
12.25K9.64K
Turnover
155.6M217.67M
Average Price
127.05225.89
Value
155.6M217.67M
Indicative Equilibrium Price
126226
Indicative Equilibrium Volume
5031K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CHEK
View details
DGNS
View details

About Diastika Biotekindo Tbk.

PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on CHEK

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS